Vomiting: Clinical Trials

209 trials for Vomiting, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

147 completed, 33 unknown, 12 terminated, 10 recruiting. 209 Phase 3, 24 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 3209Completed 147, Unknown 33, Terminated 12, Recruiting 10, Withdrawn 4, Active not recruiting 1, Not yet recruiting 1, Suspended 1
Phase 224Completed 17, Unknown 4, Recruiting 3

Follow Vomiting: new trials by email Literature Review of Vomiting trials Research Report on Vomiting

Trials (filtered) newest first · largest first

All 209 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
Tradipitant, Placebo - Nausea and Vomiting, Obesity
Phase 3RecruitingVanda Pharmaceuticals2802026-03-272026-04-20
Adding Aprepitant to a Multimodal Strategy for the Prevention of Postoperative Nausea and Vomiting in High-risk Outpatient Surgical Patients
Aprepitant 40mg, Placebo - Nausea and Vomiting, Postoperative, Prevention
Phase 3CompletedCentre hospitalier de l'Université de Montréal (CHUM)2602026-02-272026-08-27
Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting
Olanzapine, Metoclopramide - Nausea, Vomiting
Phase 3RecruitingAffiliated Hospital of Qinghai University2222026-02-032026-04-27
Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy
Olanzapine Tablets, Placebo - Breakthrough Chemotherapy-Induced Vomiting (CIV) in Pediatric Patients, Pediatric Cancer
Phase 3Not yet recruitingShanghai Children's Medical Center1002025-07-012025-06-25
Comparison of Dexmedetomidine and Dexamethasone for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy
Dexamedomedine, Dexamethasone - Postoperative Nausea and Vomiting
Phase 3CompletedPatel Hospital, Pakistan682025-06-012026-02-23
MELAtonin for Prevention of Postoperative Agitation and Emergence Delirium in Children
Melatonin, Isotonic sodium chloride solution - Emergence Delirium
Phase 3RecruitingArash Afshari6762025-01-212026-08-18
Olanzapine Versus Placebo for Moderately Emetogenic Chemotherapy
olanzapine, Placebo - Chemotherapy Induced Nausea and Vomiting
Phase 3RecruitingMahidol University1402025-01-102025-02-27
To Evaluate the Efficacy and Safety of QLM2010 for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic Chemotherapy.
QLM2010 for injection;dexamethasone, fosaprepitant dimeglumine for injection;palonosetron hydrochloride injection;dexamethasone - Chemotherapy-Induced Nausea and Vomiting
Phase 3CompletedQilu Pharmaceutical Co., Ltd.6652025-01-032025-11-18
Antiemetic Fosaprepitant To Remedy Nausea and Vomiting
Fosaprepitant 150 mg, Ondansetron 4 mg - Nausea and Vomiting, Nausea
Phase 2 / Phase 3RecruitingMontefiore Medical Center2002024-11-132026-05-18
Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting
Aprepitant Injection, Aprepitant Injection Placebo - Post-operative Nausea and Vomiting (PONV)
Phase 3UnknownCSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.4862024-10-282024-08-09
A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea And Vomiting in the Bariatric Surgery Population
Amisulpride IV Prevention, Amisulpride IV Treatment, Placebo Preventative - Post Operative Nausea and Vomiting
Phase 3UnknownBenaroya Research Institute1002024-09-132024-09-26
Opioid Free Versus Opioid Balanced Anesthesia in Ophthalmic Surgery
Dexmedetomidine, Fentanyl - Anesthesia and Analgesia, Anesthesia, Endotracheal
Phase 2 / Phase 3UnknownUniversitas Indonesia1042024-06-012024-04-30
Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients
Aprepitant Injection - Gynecological Tumor, Ovarian Cancer
Phase 3CompletedSichuan Cancer Hospital and Research Institute1432024-05-312025-12-04
NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC Regimens
Netupitant / Palonosetron Oral Capsule [Akynzeo], Olanzapine, Dexamethasone Oral - Chemotherapy-induced Nausea and Vomiting, Highly Emetogenic Chemotherapy
Phase 3CompletedFudan University6442024-05-012026-04-09
Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer
Electroacupuncture, Antiemetic Therapy, Sham electroacupuncture - Electroacupuncture, Olanzapine-contained Four-drug Antiemetic
Phase 3RecruitingFeixue Song3702024-03-072024-03-21
Oral Dexamethasone for Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy
Dexamethasone Oral, Dexamethasone - Postoperative Nausea and Vomiting
Phase 3UnknownMansoura University8142024-03-042024-03-12
Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional Dyspepsia
Itopride Hydrochloride 150 mg extended release tablets, Itopride Hydrochloride 50 mg film coated tablets - Functional Dyspepsia
Phase 3CompletedAbbott5642024-02-282026-04-03
An Evaluation the Effect of Superhydration Versus Dextrose 10% for Prevention of Post Operative Nausea and Vomiting After Laparoscopic Cholecystectomy (Prospective Randomised Controlled Study)
ringer lactate (20ml/kg), Dextrose 10% - Postoperative Nausea and Vomiting (PONV)
Phase 3CompletedAin Shams University2042024-02-252025-02-26
the Efficacy and Safety of Ondansetron Oral Soluble Pellicles
Ondansetron Oral Soluble Pellicles - Nausea and Vomiting
Phase 3UnknownThe First Affiliated Hospital of Xinxiang Medical College1842024-02-202024-02-28
Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting
Aprepitant Injection, Aprepitant Injection Placebo - Postoperative Nausea and Vomiting
Phase 3CompletedQilu Pharmaceutical (Hainan) Co., Ltd.5182024-02-022025-04-23

Showing 20 of 209. Sign in to see all of them.

Narrower conditions

Nausea (84)  ·  Postoperative Nausea and Vomiting (65)  ·  Pain, Postoperative (18)  ·  Breast Neoplasms (10)  ·  Neoplasms (10)  ·  Pain (10)  ·  Gastroparesis (8)  ·  Agnosia (5)  ·  Diarrhea (5)  ·  Uterine Cervical Neoplasms (5)  ·  Abdominal Pain (4)  ·  Diabetes Mellitus (4)  ·  Gastroenteritis (4)  ·  Hematemesis (4)

Broader conditions

Pathological Conditions, Signs and Symptoms (209)  ·  Signs and Symptoms (209)  ·  Signs and Symptoms, Digestive (208)  ·  Pathologic Processes (74)  ·  Postoperative Complications (68)  ·  Nausea (59)  ·  Neurologic Manifestations (42)  ·  Neoplasms by Site (31)  ·  Neoplasms (30)  ·  Pain (25)  ·  Digestive System Diseases (22)  ·  Gastrointestinal Diseases (21)  ·  Urogenital Diseases (15)  ·  Endocrine System Diseases (13)

Interventions

Dexamethasone (62)  ·  Ondansetron (39)  ·  Aprepitant (30)  ·  Palonosetron (25)  ·  Granisetron (20)  ·  Olanzapine (16)  ·  Calcium Dobesilate (9)  ·  Metoclopramide (9)  ·  Sodium Chloride (9)  ·  fosaprepitant (9)  ·  Saline Solution (7)  ·  netupitant, palosentron drug combination (7)  ·  casopitant (6)  ·  Gabapentin (5)  ·  ramosetron (5)

Sponsors

Merck Sharp & Dohme LLC (12)  ·  Helsinn Healthcare SA (9)  ·  Acacia Pharma Ltd (6)  ·  GlaxoSmithKline (6)  ·  M.D. Anderson Cancer Center (5)  ·  All India Institute of Medical Sciences (3)  ·  Alliance for Clinical Trials in Oncology (3)  ·  Assiut University (3)  ·  Charleston Laboratories, Inc (3)  ·  Fudan University (3)  ·  Tesaro, Inc. (3)  ·  Vanda Pharmaceuticals (3)  ·  Allergan (2)  ·  Balgrist University Hospital (2)  ·  Duchesnay Inc. (2)

Countries

United States (67)  ·  China (21)  ·  Germany (21)  ·  Canada (17)  ·  France (14)  ·  Italy (13)  ·  Russia (13)  ·  Hungary (12)  ·  Egypt (11)  ·  Poland (11)  ·  South Korea (11)  ·  Bulgaria (10)  ·  Denmark (10)  ·  India (10)  ·  Ukraine (10)

Top investigators

Dennis Vargo, MD (3)  ·  Alejandro Gonzalez-Ojeda, M.D., Ph.D. (2)  ·  Fausto Roila, MD (2)  ·  Moataz M Emara, MD, EDAIC (2)  ·  Patrick Zingg, MD (2)  ·  Sameer Bakhshi, MD (2)  ·  A. Riaz, MD (1)  ·  Alana Koehler, MD (1)  ·  Aldo Maina, M.D. (1)  ·  Alex Molassiotis, MD (1)  ·  Alex Sia (1)

Results publications

PMID 16314401, PMID 19775450, PMID 23062719, PMID 24276953, PMID 26272769, PMID 27410922, PMID 28285236, PMID 30968588, PMID 31094774, PMID 32931400, PMID 10485781, PMID 10824073, PMID 11030465, PMID 11497388, PMID 11773155, PMID 12145072, PMID 12377323, PMID 12562658, PMID 12712486, PMID 12736106, PMID 12784346, PMID 14504060, PMID 14559886, PMID 14635083, PMID 14966097, PMID 15680647, PMID 15837996, PMID 16198982, PMID 16436839, PMID 16766588, PMID 16849762, PMID 18633023, PMID 19135415, PMID 19428297, PMID 19568773, PMID 19805683, PMID 20037151, PMID 20692030, PMID 20692031, PMID 20835873, PMID 20842754, PMID 20843504, PMID 21182781, PMID 21383291, PMID 21436683, PMID 21465325, PMID 21851346, PMID 21872708, PMID 22024310, PMID 22141732

NIH funding

2014 (3), 2008 (2), 2019 (2), U10CA037420 (2), 2005 (1), 2009 (1), 2017 (1), U10CA031946 (1), U10CA081920 (1)